Abstract

Recent data suggest that early increased fibrinolysis may be associated with unfavorable prognosis in cardiac arrest. The current study aimed to assess whether there is an optimal fibrinolysis cutoff value as determined by thrombelastometry at hospital admission to predict poor outcome in a cohort of adult patients with out-of-hospital cardiac arrest. Prospective observational cohort study. Emergency department of a 2.100-bed tertiary care facility in Vienna, Austria, Europe. Patients with out-of-hospital cardiac arrest of presumed cardiac origin, subjected to targeted temperature management, who had achieved return of spontaneous circulation at admission were analyzed. None. Fibrinolysis was assessed by thrombelastometry at the bedside immediately after hospital admission and is given as maximum lysis (%). The outcome measure was the optimal cutoff for maximum lysis at hospital admission to predict poor outcome (a composite of Cerebral Performance Category 3-5 or death) at day 30, assessed by receiver operating characteristic curve analysis. Seventy-eight patients (61% male, median 59 yr) were included in the study from March 2014 to March 2017. Forty-two patients (54%) had a poor 30-day outcome including 23 nonsurvivors (30%). The maximum lysis cutoff at admission predicting poor 30-day outcome with 100% specificity (95% CI, 90-100%) was greater than or equal to 20%. Tissue-type plasminogen activator antigen levels were likewise elevated in patients with poor neurologic outcome or death 52 ng/mL (interquartile range, 26-79 ng/mL) versus 29 ng/mL (interquartile range, 17-49 ng/mL; p = 0.036). Increased fibrinolysis at admission assessed by thrombelastometry specifically predicts poor outcome in cardiac arrest with presumed cardiac etiology.

Highlights

  • The process of fibrinolysis is inevitable to regain microvessel patency and restore vital organ perfusion after intravascular clotting

  • Kaplan-Meier estimates of survival to day 30 according to maximum lysis (ML) cutoff of greater than or equal to 20% are available with the supplement (Supplemental Fig. 2, Supplemental Digital Content 1, http://links.lww.com/ CCM/D848)

  • The current study prospectively investigated the value of fibrinolysis to predict 30-day outcome early after cardiac arrest

Read more

Summary

Introduction

The process of fibrinolysis is inevitable to regain microvessel patency and restore vital organ perfusion after intravascular clotting. Endothelial tissue-type plasminogen activator (t-PA) ensures clot dissolution by converting plasminogen into plasmin at the site of primary vascular damage averting permanent circulatory compromise and subsequent thrombotic organ failure. Primary hyperfibrinolysis occurs without preceding intravascular clotting and is associated with poor outcome in several critical conditions including trauma and sepsis [1, 2]. Underlying mechanisms likely differ from that in trauma-associated fibrinolysis, which involves tissue injury and significant crystalloid hemodilution [4], previous studies likewise reported an association between the presence of fibrinolysis and unfavorable prognosis in cardiac arrest [5, 6], with the highest fibrinolytic activity found in patients with early death. Hypoperfusion resulting in release of endothelial t-PA [6] is considered one possible mechanism of fibrinolysis occurring during cardiopulmonary resuscitation (CPR) [7].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call